Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
E-Market Place- the online Market place for Health & AYUSH products launched Virtually by Dr. S. Eswara Reddy, Joint Drugs Controller, CDSCO and Mr Anil Khaitan, Former President, PHD Chamber.
India should be the Hub for API and the API schemes are to boost the indigenous manufacturing of API said by Dr. S Eswara Reddy, Joint Drugs Controller, CDSCO.
The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.
Momenta Pharmaceuticals Inc (Momenta) announced that it has entered into a definitive agreement with Johnson & Johnson (J&J). According to the agreement, J&J will acquire Momenta for USD 52.50 per share in an all-cash transaction.
Industry needs to have a transparency to gain the patient trust and awareness needs to be created through all channels and platforms said by Prof. Kiran Kalia, Director, NIPER, Ahmedabad.
US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India Limited for Ramelteon Tablets, 8 mg.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
